tiprankstipranks
MusclePharm (MSLPQ)
OTHER OTC:MSLPQ

MusclePharm (MSLPQ) Financial Statements

22 Followers

MusclePharm Financial Overview

MusclePharm's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; MusclePharm is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement-
Total Revenue$ 13.10M$ 10.04M$ 11.97M$ 14.91M$ 13.12M
Gross Profit$ 1.51M$ -527.00K$ 29.00K$ 2.18M$ 3.69M
EBIT$ -2.48M$ -1.75M$ -3.22M$ -1.60M$ 604.00K
EBITDA$ 171.00K$ 623.00K$ -3.13M$ -1.52M$ 688.00K
Net Income Common Stockholders$ -6.30M$ -6.78M$ -3.93M$ -2.25M$ 94.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 500.00K$ 1.20M$ 384.00K$ 1.02M$ 592.00K
Total Assets$ 11.98M$ 11.21M$ 11.31M$ 10.94M$ 9.95M
Total Debt$ 24.50M$ 19.48M$ 12.69M$ 11.17M$ 9.95M
Net Debt$ 24.00M$ 18.28M$ 12.30M$ 10.15M$ 9.36M
Total Liabilities$ 50.03M$ 43.40M$ 41.12M$ 37.21M$ 34.27M
Stockholders Equity$ -38.10M$ -32.20M$ -29.81M$ -26.27M$ -24.32M
Cash Flow-
Free Cash Flow$ -3.58M$ -5.58M$ -1.57M$ -996.00K$ 94.00K
Operating Cash Flow$ -3.58M$ -5.58M$ -1.57M$ -997.00K$ 98.00K
Investing Cash Flow-$ 1.00K$ 0.00$ 1.00K$ -4.00K
Financing Cash Flow$ 2.89M$ 6.41M$ 935.00K$ 1.42M$ -1.50M
Currency in USD

MusclePharm Earnings and Revenue History

MusclePharm Debt to Assets

MusclePharm Cash Flow

MusclePharm Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis